Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-28

FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' memantine hydrochloride as a generic drug (ANDA 206028) for the treatment of moderate to severe Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

ORIG AP for MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)